Merck & Co Inc
NYSE: MRK
$101.64
-$1.48 (-1.4%)
Closing Price on November 29, 2024
MRK Articles
ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company’s R&D operations. Since the return on research...
Published:
ThinkstockThe number of companies paying dividends in the S&P 500 is at a 15-year high. According to FactSet, just over 80 companies in the index do not pay dividends. Paying dividends has become...
Published:
Last Updated:
ThinkstockDrugmaker Merck & Co. Inc. (NYSE: MRK) announced Tuesday morning that it will fire another 8,500 employees in an effort to “sharpen” the company’s focus on R&D and returns to...
Published:
Last Updated:
ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual funds. In fact, the mid-September short interest...
Published:
Wikimedia CommonsChances are high that you already have heard that the Dow Jones Industrial Average (DJIA) is making a serious change among its 30 constituents. What you might not have heard outside...
Published:
Jon OggShort sellers are trying to decide what to do when it comes to how evaluate the high-yield dividend and defensive stocks. The latest short interest changes as of July 31 are compared to July...
Published:
ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on Monday by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) that it and Perrigo Co....
Published:
courtesy of Wal-Mart Stores Inc.Companies can return capital to shareholders in many ways. Dividends are one of the favored methods. So is retiring outstanding debt, as it decreases the amount of...
Published:
Last Updated:
ThinkstockShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in June and rising interest rates are obviously making...
Published:
Jon OggShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in June and rising interest rates are obviously making short...
Published:
ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers...
Published:
Last Updated:
Jon OggShort sellers have really made some big changes in their bets against the key high-yield dividend stocks that had been the darling of Wall Street. Many of these stocks are members of the Dow...
Published:
Jon OggShort sellers could have cleaned up by betting against the high dividend stocks in May and into June. Investors got a whiff of what rising interest rates might mean to their premium dividend...
Published:
This last week had much more volatility than what investors have grown used to. 24/7 Wall St. wanted to highlight the top analyst sector research calls of the week now that investors are trying to...
Published:
Last Updated:
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Published:
Last Updated: